New antiepileptic drugs in childhood. 2002

A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
Department of Paediatrics, University of Chieti, Chieti, Italy. chiarelli@unich.it

In recent years, many new antiepileptic drugs have been available for the treatment of epilepsy in pediatric age. In this review, we describe these new antiepileptic drugs (vigabatrin, lamotrigine, felbamate, gabapentin, tiagabine, topiramate) which can be used together with "old" antiepileptic drugs (e.g. phenobarbital, valproate, etc.). We report their mechanisms of action, effectiveness, dosage and side effects; moreover, some practical advice for their use in pediatric patients is given.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
February 2003, Anales de pediatria (Barcelona, Spain : 2003),
A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
August 1998, Revista de neurologia,
A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
January 2001, Epileptic disorders : international epilepsy journal with videotape,
A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
April 1995, The Western journal of medicine,
A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
February 1997, Revista de neurologia,
A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
July 2000, Annals of clinical biochemistry,
A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
January 1995, Pharmacological research,
A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
July 2001, Current neurology and neuroscience reports,
A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
May 1994, Neurology,
A Verrotti, and D Trotta, and G Morgese, and F Chiarelli
April 2009, La Revue de medecine interne,
Copied contents to your clipboard!